SH2 and SH3 domains as targets for anti-proliferative agents
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference103 articles.
1. Inhibitors of farnesyl protein transferase: a possible cancer chemotherapeutic;Scholten;Bioorg. Med. Chem.,1996
2. Protein tyrosine kinase inhibitors as novel therapeutic agents;Levitzki;Pharmacol. Ther.,1999
3. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps;Sadowski;Mol. Cell Biol.,1986
4. SH2 and SH3 domains: from structure to function;Pawson;Cell,1992
5. SH3 domains. Molecular ‘Velcro’;Morton;Curr. Biol.,1994
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High-Throughput profiling of SH2 domains using Affimer reagents: unravelling protein interaction networks;2024-03-05
2. Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis;Methods in Enzymology;2024
3. A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling;Cells;2023-08-12
4. Synthesis and Biochemical Evaluation of Monocarboxylic GRB2 SH2 Domain Inhibitors;Methods in Molecular Biology;2023
5. Advances in the previous two decades in our understanding of the post-translational modifications, functions, and drug perspectives of ArgBP2 and its family members;Biomedicine & Pharmacotherapy;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3